Valuation: DexCom, Inc.

Market Cap 33.92B 29.04B 27.09B 24.86B 46.72B 3,245B 47.64B 321B 125B 1,626B 127B 125B 5,385B P/E 2026 *
36x
P/E 2027 * 30.3x
Enterprise Value 33.16B 28.39B 26.49B 24.3B 45.67B 3,173B 46.57B 314B 122B 1,590B 124B 122B 5,264B EV / Sales 2026 *
6.34x
EV / Sales 2027 * 5.66x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+0.65%
1 week-2.54%
Current month+6.67%
1 month+14.97%
3 months+33.33%
6 months+25.20%
Current year+34.69%
1 week 76
Extreme 76
78.8
1 month 61.6
Extreme 61.6
79.2
Current year 48.5
Extreme 48.5
79.2
1 year 46.88
Extreme 46.88
79.2
3 years 46.88
Extreme 46.88
131.88
5 years 46.88
Extreme 46.88
144.55
10 years 9.12
Extreme 9.125
144.55
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-2.54% - - 33.92B
+0.22%+2.76%-13.67%+10.08% 198B
-1.58%+2.12%-0.77%+13.34% 120B
-0.77%+1.72%+3.84%+74.25% 60.51B
-0.69%-2.96%+27.89%+63.21% 53.64B
+0.03%+3.36%-5.58%-31.76% 51.1B
+0.34%-1.39%+10.46%-13.82% 33.92B
-3.89%-7.94% - - 29.75B
+0.31%+2.67%+44.25%-9.49% 24.83B
+4.23%-0.85%-7.52%+24.92% 23.01B
Average +0.02%-0.28%+7.36%+16.34% 66.14B
Weighted average by Cap. -0.25%+1.42%-0.13%+17.21%

Financials

2026 *2027 *
Net sales 5.23B 4.48B 4.18B 3.83B 7.2B 500B 7.35B 49.56B 19.32B 251B 19.64B 19.21B 830B 5.8B 4.97B 4.63B 4.25B 7.99B 555B 8.15B 54.96B 21.43B 278B 21.78B 21.3B 921B
Net income 974M 834M 778M 714M 1.34B 93.23B 1.37B 9.23B 3.6B 46.72B 3.66B 3.58B 155B 1.15B 984M 918M 842M 1.58B 110B 1.61B 10.89B 4.24B 55.1B 4.31B 4.22B 182B
Net Debt -761M -652M -608M -558M -1.05B -72.83B -1.07B -7.21B -2.81B -36.5B -2.86B -2.8B -121B -1.06B -909M -848M -778M -1.46B -102B -1.49B -10.06B -3.92B -50.9B -3.99B -3.9B -169B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
20/08/26 76.80 0.00% 20
19/08/26 €76.80 -0.26% 55
18/08/26 €77.00 +0.79% 0
17/08/26 €76.40 -1.04% 0
14/08/26 €77.20 -2.53% 0
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
89.88USD
Average target price
94.12USD
Spread / Average Target
+4.72%

Quarterly revenue - Rate of surprise